JD HEALTH INTL LTD (F:8ZN) — Market Cap & Net Worth
Market Cap & Net Worth: JD HEALTH INTL LTD (8ZN)
JD HEALTH INTL LTD (F:8ZN) has a market capitalization of $12.04 Billion (€10.30 Billion) as of September 16, 2026. Listed on the F stock exchange, this Germany-based company holds position #1929 globally and #406 in its home market, demonstrating a -4.26% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying JD HEALTH INTL LTD's stock price €3.80 by its total outstanding shares 3189531011 (3.19 Billion). Also see JD HEALTH INTL LTD total assets for a full breakdown of the balance sheet.
JD HEALTH INTL LTD Market Cap History: 2020 to 2026
JD HEALTH INTL LTD's market capitalization history from 2020 to 2026. Data shows change from $59.10 Billion to $14.18 Billion (-22.15% CAGR). Also see JD HEALTH INTL LTD (8ZN) cash flow conversion for how efficiently the company converts equity into cash flow.
JD HEALTH INTL LTD Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how JD HEALTH INTL LTD's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest JD HEALTH INTL LTD stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.31x
JD HEALTH INTL LTD's market cap is 0.31 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.20x
JD HEALTH INTL LTD's market cap is 4.20 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $59.10 Billion | $19.38 Billion | -$17.23 Billion | 3.05x | N/A |
| 2021 | $24.61 Billion | $30.68 Billion | -$1.07 Billion | 0.80x | N/A |
| 2022 | $31.71 Billion | $46.74 Billion | $380.11 Million | 0.68x | 83.42x |
| 2023 | $16.62 Billion | $53.53 Billion | $2.14 Billion | 0.31x | 7.76x |
| 2024 | $12.83 Billion | $58.16 Billion | $4.16 Billion | 0.22x | 3.08x |
| 2025 | $22.56 Billion | $73.44 Billion | $5.38 Billion | 0.31x | 4.20x |
Competitor Companies of 8ZN by Market Capitalization
Companies near JD HEALTH INTL LTD in the global market cap rankings as of September 16, 2026. Review JD HEALTH INTL LTD tangible book value ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to JD HEALTH INTL LTD by market ranking:
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2172 globally with a market cap of $10.37 Billion USD.
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2541 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
- Raia Drogasil S.A (SA:RADL3): Ranked #2963 globally with a market cap of $6.67 Billion USD ( R$34.01 Billion BRL).
- Yifeng Pharmacy (SHG:603939): Ranked #4095 globally with a market cap of $4.02 Billion USD ( CN¥27.48 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2172 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #2541 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
| #2963 | Raia Drogasil S.A | SA:RADL3 | $6.67 Billion | R$19.45 |
| #4095 | Yifeng Pharmacy | SHG:603939 | $4.02 Billion | CN¥22.67 |
JD HEALTH INTL LTD Historical Marketcap From 2020 to 2026
Between 2020 and today, JD HEALTH INTL LTD's market cap moved from $59.10 Billion to $ 14.18 Billion, with a yearly change of -22.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €14.18 Billion | -37.16% |
| 2025 | €22.56 Billion | +75.87% |
| 2024 | €12.83 Billion | -22.83% |
| 2023 | €16.62 Billion | -47.58% |
| 2022 | €31.71 Billion | +28.83% |
| 2021 | €24.61 Billion | -58.36% |
| 2020 | €59.10 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of JD HEALTH INTL LTD was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.04 Billion USD |
| MoneyControl | $12.04 Billion USD |
| MarketWatch | $12.04 Billion USD |
| marketcap.company | $12.04 Billion USD |
| Reuters | $12.04 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About JD HEALTH INTL LTD
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. Th… Read more